Sunland Fund
Overview
Sunland Fund is a Chinese private equity firm specializing in early-stage investments across various sectors. The firm focuses on biotechnology, retail, artificial intelligence, health care, health diagnostics, manufacturing, medical devices, pharmaceuticals, and product research. Sunland Fund primarily invests in early-stage ventures within China, with typical investment sizes ranging from $1 million to $5 million. The firm's investment strategy emphasizes sectors such as biotechnology, health care, and artificial intelligence, aiming to support innovative companies in these fields. Sunland Fund has a history of making multiple investments annually, indicating an active approach to identifying and supporting promising startups. While specific details about the firm's track record and investment philosophy are limited, Sunland Fund's consistent investment activity suggests a commitment to fostering growth in its target sectors. The firm's focus on early-stage ventures aligns with its strategy to nurture emerging companies in China.
Reach Sunland Fund directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Sunland Fund
What sectors does Sunland Fund invest in?
Sunland Fund invests in Retail, Health Care, Artificial Intelligence, Manufacturing, Biotechnology and Pharmaceutical, and is based in China. Sunland Fund is listed as a private equity in the ConnectSafely investor database.
Which regions does Sunland Fund invest in?
Sunland Fund invests across China.
Last updated · Source: ConnectSafely investor database
